Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ACUTE OPTIC NEURITIS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 86 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lindblom, B
      Big is significantly more beautiful?

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    2. Brissaud, O; Palin, K; Chateil, JF; Pedespan, JM
      Multiple sclerosis: pathogenesis and clinical modalities of onset in children.

      ARCHIVES DE PEDIATRIE
    3. Fox, RJ; Cohen, JA
      Multiple sclerosis: The importance of early recognition and treatment

      CLEVELAND CLINIC JOURNAL OF MEDICINE
    4. Movsas, TZ; Liu, GT; Galetta, SL; Balcer, LJ; Volpe, NJ
      Current neuro-ophthalmic therapies

      NEUROLOGIC CLINICS
    5. Roussat, B; Gohier, P; Doummar, D; Iba-Zizen, MT; Barbat, V; Jarry, D; Cabanis, EA; Hamard, H; Nordmann, JP
      Acute optic neuritis in children: clinical features and treatment. A studyof 20 cases (28 eyes)

      JOURNAL FRANCAIS D OPHTALMOLOGIE
    6. Gold, R; Buttgereit, F; Toyka, KV
      Mechanism of action of glucocorticosteroid hormones: possible implicationsfor therapy of neuroimmunological disorders

      JOURNAL OF NEUROIMMUNOLOGY
    7. Ebers, GC
      Preventing multiple sclerosis?

      LANCET
    8. Dimitri, D
      Electrophysiological diagnostic criteria of multiple sclerosis

      REVUE NEUROLOGIQUE
    9. Brochet, B
      Therapeutic indications during acute episodes of multiple sclerosis

      REVUE NEUROLOGIQUE
    10. Leussink, VI; Jung, S; Merschdorf, U; Toyka, KV; Gold, R
      High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes

      ARCHIVES OF NEUROLOGY
    11. Goodin, DS
      Therapeutic developments in multiple sclerosis

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    12. Miller, DM; Weinstock-Guttman, B; Bethoux, F; Lee, JC; Beck, G; Block, V; Durelli, L; LaMantia, L; Barnes, D; Sellebjerg, F; Rudick, RA
      A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations

      MULTIPLE SCLEROSIS
    13. Balcer, LJ; Baier, ML; Pelak, VS; Fox, RJ; Shuwairi, S; Galetta, SL; Cutter, GR; Maguire, MG
      New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis

      MULTIPLE SCLEROSIS
    14. Leocani, L; Comi, G
      Neurophysiological investigations in multiple sclerosis

      CURRENT OPINION IN NEUROLOGY
    15. Shapiro, SH; Weijer, C; Freedman, B
      Reporting the study populations of clinical trials - Clear transmission orstatic on the line?

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    16. Iannucci, G; Tortorella, C; Rovaris, M; Sormani, MP; Comi, G; Filippi, M
      Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis atpresentation

      AMERICAN JOURNAL OF NEURORADIOLOGY
    17. Sellebjerg, F; Jensen, CV; Christiansen, M
      Intrathecal IgG synthesis and autoantibody-secreting cells in multiple sclerosis

      JOURNAL OF NEUROIMMUNOLOGY
    18. Cole, SR; Beck, RW; Moke, PS; Gal, RL; Long, DT
      The National Eye Institute Visual Function Questionnaire: Experience of the ONTT

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
    19. Gronseth, GS; Ashman, EJ
      Practice parameter: The usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology

      NEUROLOGY
    20. Schmidt, J; Gold, R; Schonrock, L; Zettl, UK; Hartung, HP; Toyka, KV
      T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy

      BRAIN
    21. Caruana, PA; Davies, MB; Weatherby, SJM; Williams, R; Haq, N; Foster, DH; Hawkins, CP
      Correlation of MRI lesions with visual psychophysical deficit in secondaryprogressive multiple sclerosis

      BRAIN
    22. Frohman, EM; Racke, M; van den Noort, S
      To treat, or not to treat - The therapeutic dilemma of idiopathic monosymptomatic demyelinating syndromes

      ARCHIVES OF NEUROLOGY
    23. Sellebjerg, F; Jensen, J; Madsen, HO; Svejgaard, A
      HLA DRB1*1501 and intrathecal inflammation in multiple sclerosis

      TISSUE ANTIGENS
    24. Rice, GPA
      Treatment of secondary progressive multiple sclerosis - Current recommendations and future prospects

      BIODRUGS
    25. Miller, DH; Thompson, AJ
      Nuclear magnetic resonance monitoring of treatment and prediction of outcome in multiple sclerosis

      PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    26. Armstrong, RA
      Multiple sclerosis and the eye

      OPHTHALMIC AND PHYSIOLOGICAL OPTICS
    27. Goodin, DS
      Perils and pitfalls in the interpretation of clinical trials: A reflectionon the recent experience in multiple sclerosis

      NEUROEPIDEMIOLOGY
    28. Metz, LM; Sabuda, D; Hilsden, RJ; Enns, R; Meddings, JB
      Gastric tolerance of high-dose pulse oral prednisone in multiple sclerosis

      NEUROLOGY
    29. Brex, PA; O'Riordan, JI; Miszkiel, KA; Moseley, IF; Thompson, AJ; Plant, GT; Miller, DH
      Multisequence MRI in clinically isolated syndromes and the early development of MS

      NEUROLOGY
    30. Sailer, M; O'Riordan, JI; Thompson, AJ; Kingsley, DP; MacManus, DG; McDonald, WI; Miller, DH
      Quantitative MRI in patients with clinically isolated syndromes suggestiveof demyelination

      NEUROLOGY
    31. Buttner, U; Chofflon, M; Hess, K; Kappos, L; Kesselring, J; Ludin, H; Rihs, F; Schluep, M; Vaney, C; Baumhackl, U; Berger, T; Freimuller, O; Hartung, HP; Kollegger, W; Kristoferitsch, W; Vass, K; Lassmann, H; Markut, S; Altenkirch, H; Boese, J; Gehlen, W; Goebels, N; Gold, R; Haas, J; Haferkamp, G; Heidenreic, F; Heitmann, R; Hohlfeld, R; Jugelt, E; Kolmel, H; Konig, N; Lowitzsch, K; Manegold, U; Mertin, J; Pette, M; Poser, S; Sailer, J; Schack, G; Schulz, M; Seidel, D; Stark, E; Stoll, G; Weinrich, W; Wietholter, H; Zettl, U; Zipp, F; Zschenderlein, R; Rieckmann, P; Toyka, KV; Chan, A; Bayas, A; Maurer, M; Jung, S; Gold, R; Weilbach, F; Cursiefen, S; Flachenecker, P; Rieckmann, P
      Escalating immunomodulatory therapy of multiple sclerosis

      NERVENARZT
    32. Litwiller, SE; Frohman, EM; Zimmern, PE
      Multiple sclerosis and the urologist

      JOURNAL OF UROLOGY
    33. McDonald, WI
      Physicians, subsequence and consequence

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    34. SELLEBJERG F; CHRISTIANSEN M; GARRED P
      MBP, ANTI-MBP AND ANTI-PLP ANTIBODIES, AND INTRATHECAL COMPLEMENT ACTIVATION IN MULTIPLE-SCLEROSIS

      Multiple sclerosis
    35. Sellebjerg, F; Christiansen, M; Nielsen, PM; Frederiksen, JL
      Cerebrospinal fluid measures of disease activity in patients with multiplesclerosis

      MULTIPLE SCLEROSIS
    36. HARING G; BEHRENDT S; NOLLE B; CIRIACK G
      BILATERAL SIMULTANEOUS ACUTE AMAUROSIS AS PRIMARY MANIFESTATION OF ENCEPHALOMYELITIS DISSEMINATA

      Der Ophthalmologe
    37. RENSEL M; KINKEL RP
      A 40-YEAR-OLD WOMAN WITH A WINDMILL PATTERN OF SENSORY DISTURBANCE

      Cleveland Clinic journal of medicine
    38. BASHIR K; WHITAKER JN
      CURRENT IMMUNOTHERAPY IN MULTIPLE-SCLEROSIS

      Immunology and cell biology
    39. DOSSI BC; AMADORI A; CIRAFISI C; LORUSSO S; PASQUINELLI M; PISCAGLIA MG; RAVASIO A
      NEW THERAPEUTIC PERSPECTIVES FOR DEMYELINATING RETROBULBAR OPTIC NEURITIS

      Italian journal of neurological sciences
    40. Miller, DH
      Multiple sclerosis: Use of MRI in evaluating new therapies

      SEMINARS IN NEUROLOGY
    41. Vignes, S; Wechsler, B
      Short-term corticosteroid therapy in non malignant diseases

      REVUE DE MEDECINE INTERNE
    42. PETERSEN AA; SELLEBJERG F; FREDERIKSEN J; OLESEN J; VEJLSGAARD GL
      SOLUBLE ICAM-1, DEMYELINATION, AND INFLAMMATION IN MULTIPLE-SCLEROSISAND ACUTE OPTIC NEURITIS

      Journal of neuroimmunology
    43. SELLEBJERG F; JENSEN J; RYDER LP
      COSTIMULATORY CD80 (B7-1) AND CD86 (B7-2) ON CEREBROSPINAL-FLUID CELLS IN MULTIPLE-SCLEROSIS

      Journal of neuroimmunology
    44. SEDWICK LA; WEINSTEIN J; PURVIN V
      REAL PEOPLE, REAL PROBLEMS

      Survey of ophthalmology
    45. SELLEBJERG F; FREDERIKSEN J; NIELSEN PM; OLESEN J
      DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ORAL, HIGH-DOSEMETHYLPREDNISOLONE IN ATTACKS OF MS

      Neurology
    46. ANDERSSON PB; GOODKIN DE
      GLUCOCORTICOSTEROID THERAPY FOR MULTIPLE-SCLEROSIS - A CRITICAL-REVIEW

      Journal of the neurological sciences
    47. SELLEBJERG F; JALIASHVILI I; CHRISTIANSEN M; GARRED P
      INTRATHECAL ACTIVATION OF THE COMPLEMENT-SYSTEM AND DISABILITY IN MULTIPLE-SCLEROSIS

      Journal of the neurological sciences
    48. KARUSSIS DM; ABRAMSKY O
      IMMUNOMODULATING THERAPEUTIC APPROACHES FOR MULTIPLE-SCLEROSIS

      Journal of the neurological sciences
    49. DAVIS EA; RIZZO JF
      OCULAR MANIFESTATIONS OF MULTIPLE-SCLEROSIS

      International ophthalmology clinics
    50. MILLER DH; GROSSMAN RI; REINGOLD SC; MCFARLAND HF
      THE ROLE OF MAGNETIC-RESONANCE TECHNIQUES IN UNDERSTANDING AND MANAGING MULTIPLE-SCLEROSIS

      Brain
    51. SIMON JH
      CONTRAST-ENHANCED MR-IMAGING IN THE EVALUATION OF TREATMENT RESPONSE AND PREDICTION OF OUTCOME IN MULTIPLE-SCLEROSIS

      Journal of magnetic resonance imaging
    52. BARNES D; HUGHES RAC; MORRIS RW; WADEJONES O; BROWN P; BRITTON T; FRANCIS DA; PERKIN GD; RUDGE P; SWASH M; KATIFI H; FARMER S; FRANKEL J
      RANDOMIZED TRIAL OF ORAL AND INTRAVENOUS METHYLPREDNISOLONE IN ACUTE RELAPSES OF MULTIPLE-SCLEROSIS

      Lancet
    53. GRIMAUD J; HERMIER M; PACHAI C; CONFAVREUX C
      NMR CONTRIBUTION TO THE UNDERSTANDING OF MULTIPLE-SCLEROSIS

      Revue neurologique
    54. RUDICK RA; COHEN JA; WEINSTOCKGUTTMAN B; KINKEL RP; RANSOHOFF RM
      MANAGEMENT OF MULTIPLE-SCLEROSIS

      The New England journal of medicine
    55. HUNTER SF; WEINSHENKER BG; CARTER JL; NOSEWORTHY JH
      RATIONAL CLINICAL IMMUNOTHERAPY FOR MULTIPLE-SCLEROSIS

      Mayo Clinic proceedings
    56. ZAJICEK J
      MULTIPLE-SCLEROSIS - EARLY MANAGEMENT

      British Journal of Hospital Medicine
    57. MARTIN R; HOHLFELD R
      CURRENT IMMUNOTHERAPY OF MULTIPLE-SCLEROSIS - A REVIEW OF CLINICAL-EXPERIENCE

      CLINICAL IMMUNOTHERAPEUTICS
    58. MALONE M; LOMAESTRO B
      OUTCOMES ASSESSMENT OF DRUG-TREATMENT IN MULTIPLE-SCLEROSIS CLINICAL-TRIALS

      PharmacoEconomics
    59. MILLER DH; ALBERT PS; BARKHOF F; FRANCIS G; FRANK JA; HODGKINSON S; LUBLIN FD; PATY DW; REINGOLD SC; SIMON J
      GUIDELINES FOR THE USE OF MAGNETIC-RESONANCE TECHNIQUES IN MONITORINGTHE TREATMENT OF MULTIPLE-SCLEROSIS

      Annals of neurology
    60. ANDERSON MM; BOLY LD; BECK RW
      REMOTE CLINIC PATIENT MONITORING FOR MULTICENTER TRIALS/

      Controlled clinical trials
    61. TOURBAH A; STIEVENART JL; IBAZIZEN MT; ZANNOLI G; LYONCAEN O; CABANIS EA
      IN-VIVO LOCALIZED NMR PROTON SPECTROSCOPY OF NORMAL APPEARING WHITE-MATTER IN PATIENTS WITH MULTIPLE-SCLEROSIS

      Journal of neuroradiology
    62. WEINSTOCKGUTTMAN B; COHEN JA
      NEWER VERSUS OLDER TREATMENTS FOR RELAPSING-REMITTING MULTIPLE-SCLEROSIS

      Drug safety
    63. KILLER HE; JOB O
      DIFFERENTIAL DIAGNOSTIC CONSIDERATIONS RE GARDING RETROBULBAR NEURITIS

      Nervenarzt
    64. LYNCH SG; ROSE JW
      MULTIPLE-SCLEROSIS

      Disease-a-month
    65. ANDERSON DP
      NEUROOPHTHALMOLOGY UPDATE

      Canadian journal of ophthalmology
    66. BROD SA; LINDSEY JW; WOLINSKY JS
      MULTIPLE-SCLEROSIS - CLINICAL PRESENTATION, DIAGNOSIS AND TREATMENT

      American family physician
    67. CARTER JL
      DISEASE-MODIFYING THERAPIES FOR MULTIPLE-SCLEROSIS

      CNS DRUGS
    68. FRANCIS GS; EVANS AC; ARNOLD DL
      NEUROIMAGING IN MULTIPLE-SCLEROSIS

      Neurologic clinics
    69. STEINBRECHER A; DICHGANS J; MARTIN R
      DIAGNOSIS AND THERAPY OF MULTIPLE-SCLEROS IS

      Nervenheilkunde
    70. LEVIN LA
      OPHTHALMOLOGY

      JAMA, the journal of the American Medical Association
    71. KAPPOS L
      MULTIPLE-SCLEROSIS - DIAGNOSTIC PROCEDURE S AND NEW THERAPEUTIC DEVELOPMENTS

      Schweizerische medizinische Wochenschrift
    72. BROCHET B; GUINOT P; ORGOGOZO JM; CONFAVREUX C; RUMBACH L; LAVERGNE V; BOULLIAT J; CAUSSANEL JP; CESARO P; CHEDRU F; COLLARD M; DEGOS CF; DESTEE A; GOAS JY; GONSETTE R; FEVE JR; ROULLET E; SETIEY A; VIALLET F; WARTER JM
      DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY OF GINKGOLIDE-B IN TREATMENT OF ACUTE EXACERBATIONS OF MULTIPLE-SCLEROSIS

      Journal of Neurology, Neurosurgery and Psychiatry
    73. SCHAPIRO RT; LANGER SL
      SYMPTOMATIC THERAPY OF MULTIPLE-SCLEROSIS

      Current opinion in neurology
    74. JACOBS L; GOODKIN DE; RUDICK RA; HERNDON R
      ADVANCES IN SPECIFIC THERAPY FOR MULTIPLE-SCLEROSIS

      Current opinion in neurology
    75. SADUN AA; JUNG D
      ANNUAL-REVIEW IN NEUROOPHTHALMOLOGY .2. THE ANTERIOR VISUAL PATHWAYS

      Journal of neuro-ophthalmology
    76. WARNER J; LESSELL S
      NEUROOPHTHALMOLOGY OF MULTIPLE-SCLEROSIS

      Clinical neuroscience
    77. MILLER DH; MCDONALD WI
      NEUROIMAGING IN MULTIPLE-SCLEROSIS

      Clinical neuroscience
    78. SCHAPIRO RT
      NEW ADVANCES IN SYMPTOM MANAGEMENT IN MULTIPLE-SCLEROSIS

      Clinical neuroscience
    79. SILBERBERG DH
      SPECIFIC TREATMENT OF MULTIPLE-SCLEROSIS

      Clinical neuroscience
    80. MCDONALD WI; MILLER DH; THOMPSON AJ
      ARE MAGNETIC-RESONANCE FINDINGS PREDICTIVE OF CLINICAL OUTCOME IN THERAPEUTIC TRIALS IN MULTIPLE-SCLEROSIS - THE DILEMMA OF INTERFERON-BETA

      Annals of neurology
    81. GRIFFITHS TD; NEWMAN PK
      STEROIDS IN MULTIPLE-SCLEROSIS

      Journal of clinical pharmacy and therapeutics
    82. GOODKIN DE
      ROLE OF STEROIDS AND IMMUNOSUPPRESSION AND EFFECTS OF INTERFERON BETA-1B IN MULTIPLE-SCLEROSIS

      Western journal of medicine
    83. REDER AT; THAPAR M; JENSEN MA
      A REDUCTION IN SERUM GLUCOCORTICOIDS PROVOKES EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS - IMPLICATIONS FOR TREATMENT OF INFLAMMATORY BRAIN DISEASE

      Neurology
    84. LAMANTIA L; EOLI M; MILANESE C; SALMAGGI A; DUFOUR A; TORRI V
      DOUBLE-BLIND TRIAL OF DEXAMETHASONE VERSUS METHYLPREDNISOLONE IN MULTIPLE-SCLEROSIS ACUTE RELAPSES

      European neurology
    85. MECHTLER LL; KINKEL PR
      MAGNETIC-RESONANCE-IMAGING IN DEMYELINATING, INFECTIOUS, METABOLIC, AND CONGENITAL DISEASES

      Current opinion in neurology
    86. KELLY MA; CAVAN DA; PENNY MA; MIJOVIC CH; JENKINS D; MORRISSEY S; MILLER DH; BARNETT AH; FRANCIS DA
      THE INFLUENCE OF HLA-DR AND HLA-DQ ALLELES ON PROGRESSION TO MULTIPLE-SCLEROSIS FOLLOWING A CLINICALLY ISOLATED SYNDROME

      Human immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/08/20 alle ore 00:58:18